<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05110950</url>
  </required_header>
  <id_info>
    <org_study_id>AspiraTE2021</org_study_id>
    <nct_id>NCT05110950</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial of Endobronchial Ultrasound Needle Aspiration With and Without Suction</brief_title>
  <official_title>Diagnostic Accuracy of Endobronchial Ultrasound Needle Aspiration With and Without Suction: a Single-center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Politecnica delle Marche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università Politecnica delle Marche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of the present study is to compare the diagnostic yield of different&#xD;
      aspiration techniques in Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) in&#xD;
      the diagnosis of hilar/mediastinal adenopathy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The role of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis&#xD;
      of hilar/mediastinal adenopathy is well established. However, different aspiration techniques&#xD;
      are available and it's not clear if there's a significant difference between suction vs no&#xD;
      suction aspiration. Of great interest is the role of different aspiration techniques in&#xD;
      EBUS-TBNA in determining the diagnostic yield for histopathological evaluation, including&#xD;
      molecular biology and PD-L1 amplification assessment in lung cancer diagnosis.&#xD;
&#xD;
      In this context, no comparative studies between suction and no suction aspiration have been&#xD;
      performed; moreover, considering only suction techniques, no studies evaluated if there's a&#xD;
      difference between aspiration with EBUS dedicated syringe and manual aspiration through&#xD;
      Cameco syringe. It is very important for clinical practice to definitively assess the non&#xD;
      inferiority of no suction techniques in EBUS-TBNA in terms of diagnostic yield, and to&#xD;
      provide information regarding the quality of histologic sample to define the best diagnostic&#xD;
      strategy.&#xD;
&#xD;
      The study is focused on a minimum of 306 patients who have at least one hilar/mediastinal&#xD;
      lymph node &gt; 1 cm on CT scan or hypermetabolic on FDG-PET in at least one approachable lymph&#xD;
      nodal station for which a diagnostic cyto-histological assessment is required for clinical&#xD;
      purpose. Patients will be randomized 1:1:1 (no suction : passive suction with EBUS dedicated&#xD;
      syringe : manual suction with Cameco syringe) by a computer-generated random-allocation&#xD;
      system to undergo EBUS-TBNA with one of the three different aspiration techniques. The&#xD;
      pathologist provides a final diagnosis and, as secondary endpoint, a qualitative assessment&#xD;
      of the sample quality using both a binary and a semi-quantitative score.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 27, 2021</start_date>
  <completion_date type="Anticipated">June 26, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 26, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Both the pathologist and the patient are not aware of the type of adopted aspiration technique</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the diagnostic yield of active suction vs passive suction vs no suction EBUS-TBNA in the diagnosis of hilar/mediastinal adenopathies</measure>
    <time_frame>36 months</time_frame>
    <description>The diagnostic yield is defined as the rate of diagnoses/total of cases. Assuming that the best technique provides a diagnostic yield of 94%, the non inferiority is defined if the difference between the best and the worst method is less than 3% with a non-inferiority limit of 10%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adeguacy for molecular assessment in lung cancer</measure>
    <time_frame>36 months</time_frame>
    <description>Considering only the lung cancer diagnoses, the sample is considered adeguated is if provides all the available molecular evaluations included PD-L1 iperexpression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative evaluation of the sample by the pathologist</measure>
    <time_frame>36 months</time_frame>
    <description>The sample is evaluated by a pathologist that provides a semi-quantitative assessment of the sample, through a cell count: the sample is adeguate only if it contains more than diagnostic 100 cells.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">306</enrollment>
  <condition>Mediastinal Lymphadenopathy</condition>
  <condition>Hilar Lymphadenopathy</condition>
  <condition>Lymphoma</condition>
  <condition>Lung Neoplasms</condition>
  <condition>Sarcoidosis</condition>
  <condition>Tuberculosis</condition>
  <condition>EGF-R Positive Non-Small Cell Lung Cancer</condition>
  <condition>PDL1 Gene Mutation</condition>
  <condition>ALK Translocation</condition>
  <condition>ROS1 Gene Mutation</condition>
  <arm_group>
    <arm_group_label>No suction EBUS-TBNA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this technique the stylet is slowly removed without any kind of device in order to avoid active suction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Passive suction through dedicated EBUS-TBNA syringe</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After rapid stylet removal, suction is applied through a vacuteiner syringe, without active aspiration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual applied suction EBUS-TBNA through a pistol-grip syringe holder</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After rapid stylet removal, suction is applied through Cameco syringe pistol, that can apply active suction manually.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No suction EBUS-TBNA</intervention_name>
    <description>The needle is moved from a side to side of the lymphnode for 15 times. Each lymphnode is sampled three times.&#xD;
The samples obtained will be examined on-site by experienced blinded cytopathologist.All specimens obtained will be send to definitive cytological and histological evaluation and the final diagnosis will be collected and reported on CRFs.</description>
    <arm_group_label>No suction EBUS-TBNA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Passive suction through dedicated EBUS-TBNA syringe</intervention_name>
    <description>The needle is moved from a side to side of the lymphnode for 15 times. Each lymphnode is sampled three times.&#xD;
The samples obtained will be examined on-site by experienced blinded cytopathologist.All specimens obtained will be send to definitive cytological and histological evaluation and the final diagnosis will be collected and reported on CRFs.</description>
    <arm_group_label>Passive suction through dedicated EBUS-TBNA syringe</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Manual applied suction EBUS-TBNA through a pistol-grip syringe holder</intervention_name>
    <description>The needle is moved from a side to side of the lymphnode for 15 times. Each lymphnode is sampled three times.&#xD;
The samples obtained will be examined on-site by experienced blinded cytopathologist.All specimens obtained will be send to definitive cytological and histological evaluation and the final diagnosis will be collected and reported on CRFs..</description>
    <arm_group_label>Manual applied suction EBUS-TBNA through a pistol-grip syringe holder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ≥ 18years;&#xD;
&#xD;
          -  presence of at least one hilar/mediastinal adenopathy &gt;1 cm on short axis assessed by&#xD;
             contrast-enhanced CT scan and/or hypermetabolic adenopathy assessed by FDG-PET;&#xD;
&#xD;
          -  ability to give an informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  coagulopathy or bleeding diathesis that cannot be corrected;&#xD;
&#xD;
          -  severe refractory hypoxemia;&#xD;
&#xD;
          -  unstable hemodynamic status;&#xD;
&#xD;
          -  inability to give an informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefano Gasparini, MD</last_name>
    <phone>0715964353</phone>
    <email>s.gasparini@univpm.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francesca Gonnelli, MD</last_name>
    <email>francesca.gonnelli@ospedaliriuniti.marche.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pulmonary Diseases Unit, Department of Immunoallergic and Respiratory Diseases, Azienda Ospedaliero Universitaria 'Ospedali Riuniti' Ancona</name>
      <address>
        <city>Ancona</city>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Stefano Gasparini, MD</last_name>
      <phone>0715934353</phone>
      <email>s.gasparini@univpm.it</email>
    </contact>
    <contact_backup>
      <last_name>Francesca Gonnelli, MD</last_name>
      <email>francesca.gonnelli@ospedaliriuniti.marche.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Labarca G, Folch E, Jantz M, Mehta HJ, Majid A, Fernandez-Bussy S. Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2018 Oct;15(10):1205-1216. doi: 10.1513/AnnalsATS.201801-045OC.</citation>
    <PMID>30011388</PMID>
  </results_reference>
  <results_reference>
    <citation>Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla M, Lamb C, Casey KR, Patel S, Silvestri GA, Feller-Kopman DJ. Technical Aspects of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report. Chest. 2016 Mar;149(3):816-35. doi: 10.1378/chest.15-1216. Epub 2016 Jan 12. Review.</citation>
    <PMID>26402427</PMID>
  </results_reference>
  <results_reference>
    <citation>He X, Wu Y, Wang H, Yu G, Xu B, Jia N, Yao Z. Slow-pull capillary technique versus suction technique in endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing diseases involving hilar and mediastinal lymph node enlargement. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620907037. doi: 10.1177/1753466620907037.</citation>
    <PMID>32103709</PMID>
  </results_reference>
  <results_reference>
    <citation>Lin X, Ye M, Li Y, Ren J, Lou Q, Li Y, Jin X, Wang KP, Chen C. Randomized controlled trial to evaluate the utility of suction and inner-stylet of EBUS-TBNA for mediastinal and hilar lymphadenopathy. BMC Pulm Med. 2018 Dec 7;18(1):192. doi: 10.1186/s12890-018-0751-0.</citation>
    <PMID>30526587</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Politecnica delle Marche</investigator_affiliation>
    <investigator_full_name>Stefano Gasparini</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Lymphadenopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

